🔎 Trials Near Me

Utama › Penyakit Sel Sabit › New York › New York City

Kajian klinikal Penyakit Sel Sabit di New York City, NY

13 kajian untuk Penyakit Sel Sabit sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Mengambil pesertaFasa 1
  • Mount Sinai Hospital, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Mengambil pesertaFasa 3
  • Columbia University Medical Center_New York_0, New York
  • Columbia University Medical Center_New York_0, New York
Umur 2 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06609226

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Mengambil pesertaFasa 2/3
  • Icahn School of Medicine at Mount Sinai, New York
Umur 12 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Mengambil pesertaKajian pemerhatian
  • Weill Cornell Medical College - New York Presbyterian Hospital, New York
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Mengambil pesertaFasa 2
  • Mount Sinai Medical Center, New York
Umur 12 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06699849

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

Mengambil pesertaFasa 1/2
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering, New York
Umur 12 hingga 50 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT04819841

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Mengambil pesertaFasa 1
  • Columbia University Irving Medical Center, New York
Umur 12 hingga 50 · Semua jantina · Dikemas kini 10 Jun 2026 · NCT07015684

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Mengambil pesertaKajian pemerhatian
  • Columbia Presbytarian (NT-DMT), New York
Umur 3 hingga 20 · Semua jantina · Dikemas kini 4 Jun 2026 · NCT06941389

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Mengambil pesertaFasa 3
  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Umur 12 hingga 35 · Semua jantina · Dikemas kini 23 Mac 2026 · NCT05477563

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Mengambil pesertaFasa 2
  • Columbia University, New York
Umur 2 hingga 25 · Semua jantina · Dikemas kini 10 Mac 2026 · NCT03587272

A Long-term Follow-up Study in Patients Who Received BEAM-101

Mengambil pesertaKajian pemerhatian
  • Columbia University Irving Medical Center, New York
Umur 14 hingga 37 · Semua jantina · Dikemas kini 28 Jan 2026 · NCT07373639

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Mengambil peserta
  • Weil Cornell Medical College, New York
Umur 16 hingga 30 · Semua jantina · Dikemas kini 7 Jan 2026 · NCT06374238

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

Mengambil pesertaFasa 2
  • Mount Sinai Hospital, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2025 · NCT05519111

Kajian Penyakit Sel Sabit di bandar lain

Kajian lain di New York City

Daripada ClinicalTrials.gov, data diperoleh pada 7 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.